Literature DB >> 19803709

Hyperbaric oxygen therapy as an anti-infective agent.

Maide Cimşit1, Günalp Uzun, Senol Yildiz.   

Abstract

Hyperbaric oxygen therapy (HBOT) involves inhalation of 100% oxygen at supra-atmospheric ambient pressure. HBOT is used as either a primary or adjunctive treatment in the management of infections such as gas gangrene, necrotizing fasciitis, diabetic foot infections, refractory osteomyelitis, neurosurgical infections and fungal infections. HBOT acts as a bactericidal/bacteriostatic agent against anerobic bacteria by increasing the formation of free oxygen radicals. HBOT restores the bacterial-killing capacity of leukocytes in hypoxic wounds by increasing tissue oxygen tensions. In addition, HBOT acts synergistically with a number of antibiotics. This article reviews the anti-infective effects of HBOT and the use of HBOT in the treatment of certain infectious diseases.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19803709     DOI: 10.1586/eri.09.76

Source DB:  PubMed          Journal:  Expert Rev Anti Infect Ther        ISSN: 1478-7210            Impact factor:   5.091


  21 in total

1.  Hyperbaric oxygen therapy as an adjunct to surgical treatment of extensive hidradenitis suppurativa.

Authors:  Günalp Uzun; Yavuz Ozdemir; Mesut Mutluoğlu; Bülent Güleç
Journal:  World J Surg       Date:  2010-04       Impact factor: 3.352

Review 2.  Antimicrobial strategies centered around reactive oxygen species--bactericidal antibiotics, photodynamic therapy, and beyond.

Authors:  Fatma Vatansever; Wanessa C M A de Melo; Pinar Avci; Daniela Vecchio; Magesh Sadasivam; Asheesh Gupta; Rakkiyappan Chandran; Mahdi Karimi; Nivaldo A Parizotto; Rui Yin; George P Tegos; Michael R Hamblin
Journal:  FEMS Microbiol Rev       Date:  2013-07-25       Impact factor: 16.408

3.  The bactericidal effect of 470-nm light and hyperbaric oxygen on methicillin-resistant Staphylococcus aureus (MRSA).

Authors:  Violet Vakunseh Bumah; Harry Thomas Whelan; Daniela Santos Masson-Meyers; Brendan Quirk; Ellen Buchmann; Chukuka Samuel Enwemeka
Journal:  Lasers Med Sci       Date:  2015-02-21       Impact factor: 3.161

4.  Hyperbaric Oxygen for Lower Limb Trauma (HOLLT): an international multi-centre randomised clinical trial.

Authors:  Ian L Millar; Folke G Lind; Karl-Åke Jansson; Michal Hájek; David R Smart; Tiago D Fernandes; Rosemary A McGinnes; Owen D Williamson; Russell K Miller; Catherine A Martin; Belinda J Gabbe; Paul S Myles; Peter A Cameron
Journal:  Diving Hyperb Med       Date:  2022-09-30       Impact factor: 1.228

5.  Hyperbaric oxygen therapy for diabetic foot wounds: has hope hurdled hype?

Authors:  Benjamin A Lipsky; Anthony R Berendt
Journal:  Diabetes Care       Date:  2010-05       Impact factor: 19.112

6.  Adjunctive Hyperbaric Oxygen Therapy or Alone Antibiotherapy? Methicillin Resistant Staphylococcus aureus Mediastinitis in a Rat Model.

Authors:  Tolga Kurt; Ahmet Vural; Ahmet Temiz; Ersan Ozbudak; Ali Umit Yener; Suzan Sacar; Mustafa Sacar
Journal:  Braz J Cardiovasc Surg       Date:  2015 Sep-Oct

7.  Hyperbaric oxygen therapy as an adjunctive treatment for sternal infection and osteomyelitis after sternotomy and cardiothoracic surgery.

Authors:  Wen-Kuang Yu; Yen-Wen Chen; Huei-Guan Shie; Te-Cheng Lien; Hsin-Kuo Kao; Jia-Horng Wang
Journal:  J Cardiothorac Surg       Date:  2011-10-17       Impact factor: 1.637

8.  The pacific chapter annual meeting of the undersea & hyperbaric medical society.

Authors:  Robert P Ostrowski; Takkin Lo; John H Zhang
Journal:  Med Gas Res       Date:  2011-08-04

9.  Bacterial drug tolerance under clinical conditions is governed by anaerobic adaptation but not anaerobic respiration.

Authors:  Claudia M Hemsley; Jamie X Luo; Clio A Andreae; Clive S Butler; Orkun S Soyer; Richard W Titball
Journal:  Antimicrob Agents Chemother       Date:  2014-07-21       Impact factor: 5.191

Review 10.  Hyperbaric oxygen treatment in three cases of necrotizing infection of the neck.

Authors:  Torbjørn Nedrebø; Trond Bruun; Rune Skjåstad; Gunhild Holmaas; Steinar Skrede
Journal:  Infect Dis Rep       Date:  2012-02-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.